-- Sarah Fitzgerald, HNS Correspondent
Seniors across the country are expressing their excitement about a new breakthrough in vision and eye health called Macutren.
With more than 10,000 baby boomers retiring every single day, it’s no surprise that the number of concerns around deteriorating vision are on the rise as well. Age-related vision loss is a common issue that many seniors face. The reasons for this can vary from person to person, but free radical damage caused by exposure to sunlight, electronic screens, and pollution are frequently to blame.
With over 263 million cars in the United States alone (as of 2015) combined with 77% of Americans owning smartphones, and 84% of Americans owning computers, the exposure to the kinds of things that have a disastrous effect on human eyesight is at dramatically high levels. More people than ever before are either experiencing or at higher risk of age-related vision loss and that rate is expected to increase significantly over the next 5-10 years. So when news began to spread about the benefits of Macutren, many seniors were understandably excited.
Research conducted at top universities around the country have found that the active ingredients in Macutren show many promising findings. Experts concluded that this new product could be a real ‘gamechanger’ for the eye health industry, and based on the initial market feedback so far, many users of Macutren have been reporting remarkable results.
Unfortunately, because of the rapid rise in demand for the product, many seniors haven’t been able to find Macutren in time. It is only produced in limited quantities in a United States based, FDA-registered facility conforming to Good Manufacturing Practices (GMP), so the amount of available inventory is directly linked to demand for the product. Based on the initial response, this means the company could sell out for months at a time.
Release ID: 299367